[ad_1]
Shares of Nike Inc. fell after hours on Thursday after the sneaker maker reported quarterly sales that missed Wall Street’s estimates, saying the results “highlighted challenges” that led the company to adjust its outlook for the fiscal year ahead.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...